Selvita Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Boguslaw Sieczkowski

Chief executive officer

zł1.1m

Total compensation

CEO salary percentage59.8%
CEO tenureno data
CEO ownership5.1%
Management average tenure2.8yrs
Board average tenureno data

Recent management updates

Recent updates

CEO Compensation Analysis

How has Boguslaw Sieczkowski's remuneration changed compared to Selvita's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2024n/an/a

zł54m

Jun 30 2024n/an/a

zł47m

Mar 31 2024n/an/a

zł65m

Dec 31 2023zł1mzł658k

zł70m

Sep 30 2023n/an/a

zł20m

Jun 30 2023n/an/a

zł31m

Mar 31 2023n/an/a

zł24m

Dec 31 2022zł1mzł480k

zł26m

Sep 30 2022n/an/a

zł20m

Jun 30 2022n/an/a

zł11m

Mar 31 2022n/an/a

zł12m

Dec 31 2021zł1mzł1m

zł15m

Sep 30 2021n/an/a

zł12m

Jun 30 2021n/an/a

zł18m

Mar 31 2021n/an/a

zł22m

Dec 31 2020zł697kn/a

zł18m

Sep 30 2020n/an/a

zł21m

Jun 30 2020n/an/a

zł15m

Mar 31 2020n/an/a

zł9m

Dec 31 2019zł186kzł113k

zł7m

Compensation vs Market: Boguslaw's total compensation ($USD267.39K) is below average for companies of similar size in the German market ($USD907.18K).

Compensation vs Earnings: Boguslaw's compensation has been consistent with company performance over the past year.


CEO

Boguslaw Sieczkowski

no data

Tenure

zł1,100,903

Compensation

Mr. Boguslaw Stanislaw Sieczkowski, M.B.A, is Chief Executive Officer and Chairman of Management Board at SELVITA S.A. Mr. Sieczkowski served as Chief Operating Officer, Executive Vice President and Vice P...


Leadership Team

NamePositionTenureCompensationOwnership
Boguslaw Sieczkowski
Chairman of Management Board & CEOno datazł1.10m5.13%
€ 11.2m
Milosz Gruca
Global Head of Drug Developmentno datazł1.09m0.33%
€ 724.8k
Dariusz Kurdas
CFO & Member of the Management Board5.3yrszł590.72k0.023%
€ 51.1k
Miroslawa Zydron
COO & Member of the Management Board2.8yrszł644.19k0.23%
€ 511.9k
Dawid Radziszewski
General Counsel & Member of the Management Boardno datazł672.21k0.024%
€ 53.3k
Adrijana Vinter
Global Head of Drug Discovery & Member of the Management Board2.8yrszł1.25m0.065%
€ 143.2k
Paul Overton
Chief Commercial Officerno datano datano data

2.8yrs

Average Tenure

Experienced Management: 787's management team is considered experienced (2.8 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/18 12:53
End of Day Share Price 2024/12/18 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Selvita S.A. is covered by 9 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamil KliszczBiuro maklerskie mBanku
Beata Szparaga-WasniewskaBiuro maklerskie mBanku
Sylwia JaskiewiczDom Maklerski Banku Ochrony Srodowiska S.A.